Health Care · Biotechnology
Market capitalization divided by trailing twelve-month revenue. A valuation metric often used when earnings are negative or not meaningful.
Latest P/S Ratio
26004.57x
As of Dec 30, 2025
Beyond P/S Ratio, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | P/S Ratio |
|---|---|
| Dec 30, 2025 | 26004.57x |
| Dec 29, 2025 | 27939.80x |
| Dec 26, 2025 | 29391.21x |
| Dec 24, 2025 | 28181.70x |
| Dec 23, 2025 | 27335.04x |
| Dec 22, 2025 | 28423.60x |
| Dec 19, 2025 | 26488.38x |
| Dec 18, 2025 | 24674.11x |
P/S Ratio = Market Capitalization / Revenue (TTM)
P/S ignores profitability and capital structure, making it a simple but blunt valuation tool.
Read the general P/S Ratio definition, formula, and analyst usage guide.
P/S Ratio guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison